---
title: "STERLING NEWCASTLE LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ffdf5b60-af31-5a5b-be3f-99b27be27c20
json: https://whiteintel.dev/api/public/dossier/ffdf5b60-af31-5a5b-be3f-99b27be27c20
identifier: oo:GB-COH-04411457
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# STERLING NEWCASTLE LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-04411457`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/ffdf5b60-af31-5a5b-be3f-99b27be27c20  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ffdf5b60-af31-5a5b-be3f-99b27be27c20  

## Ownership & control

### Owners / controllers

- **Dr Robert Graham Tyson** (beneficial owner) — 50% — https://whiteintel.dev/entity/c52385b5-466d-506a-ba2b-11b8daef66e1
- **Professor Bernard Thomas Golding** (beneficial owner) — 50% — https://whiteintel.dev/entity/f48efc84-0bfa-53d6-a5fe-4ff8a68462f5
- **STERLING PHARMA SOLUTIONS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/1cb0f8e2-dbe4-5491-bf48-b83c4657ad89
- **Professor Bernard Thomas Golding** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/fa47f818-056a-43ad-a5e5-b01b54876ef9
- **Dr Robert Graham Tyson** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/0d68a92e-adbe-4f1e-ba0d-adc1d778b180

### UBO chain (walk to the ultimate owner)

A **19-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `04411457`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2002-04-08
- **Registered office:** Sterling Place, Dudley, Cramlington, Northumberland, NE23 7QG, England
- **SIC:** 72190

### Officers

- MAGUIRE, Septima — director · Irish · appointed 2026-05-05
- ROTTHIER, Karl — director · Belgian · appointed 2025-11-03
- CHRISTENSEN, Paul Andrew, Dr — secretary · British · appointed 2002-10-02 · resigned 2005-07-26
- PALMER, Derek Reginald, Dr — secretary · British · appointed 2002-04-10 · resigned 2002-09-09
- SCOTT, Keith, Professor — secretary · British · appointed 2005-07-26 · resigned 2008-12-15
- TYSON, Robert, Dr — secretary · British · appointed 2008-12-15 · resigned 2023-10-12
- RWL REGISTRARS LIMITED — corporate nominee secretary · appointed 2002-04-08 · resigned 2002-04-10
- ANDERSON, Matthew David — director · American · appointed 2025-02-17 · resigned 2026-05-05
- CHRISTENSEN, Paul Andrew, Dr — director · British · appointed 2002-10-02 · resigned 2005-07-26
- COOK, Kevin — director · British · appointed 2025-02-17 · resigned 2025-10-31
- DAVIES, Tim — director · British · appointed 2023-10-12 · resigned 2025-02-16
- GIBSON, Mike — director · British · appointed 2023-10-12 · resigned 2025-02-16
- GOLDING, Bernard Thomas, Professor — director · British · appointed 2002-10-02 · resigned 2023-10-12
- SCOTT, Keith, Professor — director · British · appointed 2002-10-02 · resigned 2008-12-15
- TYSON, Robert Graham, Dr — director · British · appointed 2002-04-10 · resigned 2023-10-12
- BONUSWORTH LIMITED — corporate nominee director · appointed 2002-04-08 · resigned 2002-04-10

### Beneficial owners (Persons with Significant Control)

- [Sterling Pharma Solutions Limited](https://whiteintel.dev/entity/1cb0f8e2-dbe4-5491-bf48-b83c4657ad89) — 75–100% shares · corporate PSC · England — since 2023-10-12
- Dr Robert Graham Tyson — 25–50% shares · individual PSC — ceased 2023-10-12
- Professor Bernard Thomas Golding — 25–50% shares · individual PSC — ceased 2023-10-06

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/04411457
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/04411457

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **STERLING NEWCASTLE LIMITED** — https://whiteintel.dev/entity/ffdf5b60-af31-5a5b-be3f-99b27be27c20 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **STERLING NEWCASTLE LIMITED**. Human view: https://whiteintel.dev/entity/ffdf5b60-af31-5a5b-be3f-99b27be27c20 · Structured JSON: https://whiteintel.dev/api/public/dossier/ffdf5b60-af31-5a5b-be3f-99b27be27c20._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._